| UBS (LUX) EQUITY SICAV - EUROPEAN HIGH DIVIDEND (EUR) (CHF) QL-ACC | RVI EUROPA VALOR | 35,91% | 53,79% | 57,66% | · |
| FRANKLIN BIOTECHNOLOGY DISCOVERY I (ACC) USD | BIOTECNOLOGÍA | 74,58% | 82,15% | 57,65% | 148,52% |
| WAVERTON GLOBAL EQUITY FUND A USD DIS | RVI GLOBAL | 22,20% | 46,22% | 57,65% | 159,64% |
| FIDELITY MSCI EUROPE INDEX FUND P-ACC-EUR (H) | RVI EUROPA | 33,08% | 41,87% | 57,64% | · |
| AMUNDI MSCI EMU ESG SELECTION RHG CAP | RV EURO | 33,00% | 46,20% | 57,63% | · |
| DWS ESG AKKUMULA LC | RVI GLOBAL | 31,66% | 50,96% | 57,62% | 179,20% |
| AB SICAV I-GLOBAL VALUE PORTFOLIO A EUR | RVI GLOBAL VALOR | 33,57% | 57,25% | 57,61% | 127,81% |
| DWS ESG AKKUMULA ID | RVI GLOBAL | 31,55% | 50,65% | 57,60% | 179,91% |
| PRIVILEDGE - JPMORGAN US EQUITIES BETA ENHANCED (USD) M DIS | RVI USA | 15,45% | 50,13% | 57,57% | 209,94% |
| UBS S&P 500 ESG ELITE UCITS ETF HGBP DIS | RVI USA | -7,47% | 49,16% | 57,57% | · |
